von Willebrand disease: still an intriguing disorder in the era of molecular medicine.
about
Laboratory issues in bleeding disorders.Evaluation of laboratory methods to improve characterization of dogs with von Willebrand disease.Mechanisms of oral bacteria-induced platelet activation.Application of UKHCDO 2004 guidelines in type 1 von Willebrand Disease--a single centre paediatric experience of the implications of altered or removed diagnosis.Analysis of von Willebrand factor multimers by simultaneous high- and low-resolution vertical SDS-agarose gel electrophoresis and Cy5-labeled antibody high-sensitivity fluorescence detection.Measurement of von Willebrand factor activity: relative effects of ABO blood type and race.Reduced toxicity of F-deficient Sendai virus vector in the mouse fetus.Germline de novo mutations and linkage markers vs. DNA sequencing for carrier detection in von Willebrand disease.Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method.Vascular anatomy of the small intestine-a comparative anatomic study on humans and pigs.Evaluation of a rapid automated assay for analysis of von Willebrand ristocetin cofactor activity.HMGB1 facilitates hypoxia-induced vWF upregulation through TLR2-MYD88-SP1 pathway.The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study.
P2860
Q36473056-10EFEA18-896B-4D92-A31B-D330ED5414F8Q37377002-BEE0A131-2190-484C-97AC-95D39BAB7A60Q37765801-D38A4C74-9736-48EF-99C6-98035A2DD3F1Q37849337-92BF39D1-18C2-475D-9299-C9D9A510DB99Q43186685-670BC83F-C445-4859-A6AA-85718C7A1C1DQ44604242-A2251962-93B6-458E-A3EF-360AFD428AABQ45699077-5E4D3801-825E-4227-BE56-677A3E2B6F0CQ45863954-C3FA3CAA-0BD4-4A72-9B75-ACA5BEF5A203Q45877641-D5324F42-B2B4-49DF-9ED3-7AC057B21C20Q46770687-D8FBE747-3502-43FA-A862-07251E46914CQ46917484-0C6C8BA3-8578-455A-AD92-230BF413489AQ51601980-8CDCA5D3-F609-403F-A4E2-96FDCF837D45Q51958036-4BDC87D8-656C-47E1-A3DF-5513389DCD02
P2860
von Willebrand disease: still an intriguing disorder in the era of molecular medicine.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
von Willebrand disease: still an intriguing disorder in the era of molecular medicine.
@ast
von Willebrand disease: still an intriguing disorder in the era of molecular medicine.
@en
von Willebrand disease: still an intriguing disorder in the era of molecular medicine.
@nl
type
label
von Willebrand disease: still an intriguing disorder in the era of molecular medicine.
@ast
von Willebrand disease: still an intriguing disorder in the era of molecular medicine.
@en
von Willebrand disease: still an intriguing disorder in the era of molecular medicine.
@nl
prefLabel
von Willebrand disease: still an intriguing disorder in the era of molecular medicine.
@ast
von Willebrand disease: still an intriguing disorder in the era of molecular medicine.
@en
von Willebrand disease: still an intriguing disorder in the era of molecular medicine.
@nl
P2860
P1433
P1476
von Willebrand disease: still an intriguing disorder in the era of molecular medicine.
@en
P2093
Rodeghiero F
P2860
P304
P356
10.1046/J.1365-2516.2002.00611.X
P577
2002-05-01T00:00:00Z